TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from 180 Life Sciences ( (ATNF) ).
On July 1, 2025, 180 Life Sciences Corp. announced the strengthening of its legacy intellectual property assets with the grant of a U.S. patent for methods to prevent or reduce post-operative cognitive decline and a Notice of Allowance from the Canadian Intellectual Property Office for a method to treat localized fibrotic disorders. These developments enhance the company’s proprietary platform in neuroinflammation and fibrosis, positioning these assets for potential future partnerships or licensing deals, thereby potentially increasing shareholder value.
More about 180 Life Sciences
180 Life Sciences Corp. is an innovative biotechnology company that is currently transitioning to the global interactive technology sector, with a focus on iGaming. The company aims to leverage its proprietary Technology Gaming Platform and expertise through the acquisition or development of online casino and related entertainment businesses.
Average Trading Volume: 137,541
Technical Sentiment Signal: Sell
Current Market Cap: $4.62M
For a thorough assessment of ATNF stock, go to TipRanks’ Stock Analysis page.